CLINICAL_TRIALS
trial_result
· 2019-07-23
Clinical Trial Update: Gentamicin for RDEB [Phase 1, Phase 2]
Summary
Phase 1/2 trial of gentamicin for Recessive Dystrophic Epidermolysis Bullosa has completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Southern California | Conditions: Recessive Dystrophic Epidermolysis Bullosa | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-07-23